Dyne Therapeutics (NASDAQ:DYN) Price Target Raised to $42.00
Dyne Therapeutics (NASDAQ:DYN – Get Free Report) had its price target boosted by analysts at Jefferies Financial Group from $36.00 to $42.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price target would indicate a potential upside […]
More Stories
Evaxion Biotech A/S (NASDAQ:EVAX) Short Interest Up 285.7% in December
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) was the recipient of a significant increase in short interest during the...
First Trust Emerging Markets Small Cap AlphaDEX Fund (NASDAQ:FEMS) Sees Large Increase in Short Interest
First Trust Emerging Markets Small Cap AlphaDEX Fund (NASDAQ:FEMS – Get Free Report) was the target of a large increase...
InvescoBulletShares2033 Corporate Bond ETF (NASDAQ:BSCX) Short Interest Update
InvescoBulletShares2033 Corporate Bond ETF (NASDAQ:BSCX – Get Free Report) saw a large increase in short interest in the month of...
SMC Entertainment, Inc. (OTCMKTS:SMCE) Short Interest Update
SMC Entertainment, Inc. (OTCMKTS:SMCE – Get Free Report) was the target of a large growth in short interest in December....
Mitsui & Co., Ltd. (OTCMKTS:MITSY) Short Interest Up 313.3% in December
Mitsui & Co., Ltd. (OTCMKTS:MITSY – Get Free Report) was the target of a significant growth in short interest during...
The Arena Group Holdings, Inc. Accepted by NYSE American for Compliance Plan
The Arena Group Holdings, Inc. (NYSE: AREN) recently received notice that its compliance plan to meet NYSE American’s continued listing...